We took telemedicine to a whole new level. Invented the first Precision Medicine platform. And didn't survive the Covid-19 crisis. Thank you. We'll miss you.
As a company, we may have run out of money and ceased operations... but that doesn't stop us from being one of the top 10 hottest startups!
https://t.co/XvklvxxWyv
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers | Journal for ImmunoTherapy of Cancer - https://t.co/d0onzL39ez